• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度尼西亚伊里安查亚地区间日疟原虫感染患者的全血氯喹浓度。

Whole blood chloroquine concentrations with Plasmodium vivax infection in Irian Jaya, Indonesia.

作者信息

Baird J K, Leksana B, Masbar S, Sutanihardja M A, Fryauff D J, Subianto B

机构信息

U.S. Naval Medical Research Unit No. 2, Jakarta, Indonesia.

出版信息

Am J Trop Med Hyg. 1997 Jun;56(6):618-20. doi: 10.4269/ajtmh.1997.56.618.

DOI:10.4269/ajtmh.1997.56.618
PMID:9230791
Abstract

Whole blood concentrations of self-administered chloroquine (CQ) and its metabolite desethylchloroquine (DCQ) were measured in 168 patients with microscopically confirmed infection by Plasmodium vivax in northeastern Irian Jaya, Indonesia. The study consisted of both survey and passive case detection in four separate villages between 1992 and 1994. The subjects were Javanese people 4-51 years old who had lived in the Arso region for up to two years. The sum of CQ and DCQ ranged from 0 to 8,342 ng/ml of whole blood, and 122 subjects (73%) had > or = 100 ng/ml of CQ plus DCQ, the estimated minimally effective concentration (MEC) in whole blood against chloroquine-sensitive P. vivax. Among 56 subjects reporting to a clinic with symptoms of malaria, 53 (95%) had ordinarily effective levels of chloroquine in blood. Among 109 largely asymptomatic malaria patients found by survey case detection, 69 (63%) had chloroquine blood levels greater than the MEC. Virtually all clinical and most subclinical vivax malaria in this region occurs despite ordinarily effective levels of chloroquine in blood.

摘要

在印度尼西亚伊里安查亚省东北部,对168例经显微镜确诊为间日疟原虫感染的患者进行了自服氯喹(CQ)及其代谢产物去乙基氯喹(DCQ)的全血浓度测定。该研究在1992年至1994年期间,于四个不同的村庄开展了调查和被动病例检测。研究对象为4至51岁、在阿尔索地区居住长达两年的爪哇人。全血中CQ与DCQ浓度之和为0至8342纳克/毫升,122名受试者(73%)的CQ加DCQ浓度≥100纳克/毫升,这是全血中针对氯喹敏感间日疟原虫的估计最低有效浓度(MEC)。在56名因疟疾症状到诊所就诊的受试者中,53人(95%)血液中的氯喹水平通常有效。在通过调查病例检测发现的109名基本无症状的疟疾患者中,69人(63%)的氯喹血药浓度高于MEC。尽管该地区血液中氯喹水平通常有效,但几乎所有临床和大多数亚临床间日疟仍有发生。

相似文献

1
Whole blood chloroquine concentrations with Plasmodium vivax infection in Irian Jaya, Indonesia.印度尼西亚伊里安查亚地区间日疟原虫感染患者的全血氯喹浓度。
Am J Trop Med Hyg. 1997 Jun;56(6):618-20. doi: 10.4269/ajtmh.1997.56.618.
2
In vivo resistance to chloroquine by Plasmodium vivax and Plasmodium falciparum at Nabire, Irian Jaya, Indonesia.印度尼西亚伊里安查亚省纳比雷间日疟原虫和恶性疟原虫对氯喹的体内抗药性
Am J Trop Med Hyg. 1997 Jun;56(6):627-31. doi: 10.4269/ajtmh.1997.56.627.
3
In vivo responses to antimalarials by Plasmodium falciparum and Plasmodium vivax from isolated Gag Island off northwest Irian Jaya, Indonesia.来自印度尼西亚伊里安查亚省西北部偏远的加格岛的恶性疟原虫和间日疟原虫对抗疟药的体内反应。
Am J Trop Med Hyg. 1999 Apr;60(4):542-6. doi: 10.4269/ajtmh.1999.60.542.
4
Very high risk of therapeutic failure with chloroquine for uncomplicated Plasmodium falciparum and P. vivax malaria in Indonesian Papua.在印度尼西亚巴布亚地区,氯喹治疗非复杂性恶性疟原虫和间日疟原虫疟疾的治疗失败风险非常高。
Am J Trop Med Hyg. 2003 Apr;68(4):416-20.
5
Survey of in vivo sensitivity to chloroquine by Plasmodium falciparum and P. vivax in Lombok, Indonesia.印度尼西亚龙目岛恶性疟原虫和间日疟原虫对氯喹的体内敏感性调查。
Am J Trop Med Hyg. 1997 Feb;56(2):241-4. doi: 10.4269/ajtmh.1997.56.241.
6
Survey of resistance to chloroquine by Plasmodium vivax in Indonesia.印度尼西亚间日疟原虫对氯喹的抗药性调查。
Trans R Soc Trop Med Hyg. 1996 Jul-Aug;90(4):409-11. doi: 10.1016/s0035-9203(96)90526-x.
7
Chloroquine-resistant Plasmodium vivax malaria in Debre Zeit, Ethiopia.埃塞俄比亚德布雷齐特的抗氯喹间日疟原虫疟疾
Malar J. 2008 Oct 29;7:220. doi: 10.1186/1475-2875-7-220.
8
Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels.间日疟原虫对氯喹耐药性的诊断:复发时间及全血氯喹水平
Am J Trop Med Hyg. 1997 Jun;56(6):621-6. doi: 10.4269/ajtmh.1997.56.621.
9
Chloroquine-resistant Plasmodium malariae in south Sumatra, Indonesia.印度尼西亚南苏门答腊的抗氯喹恶性疟原虫。
Lancet. 2002 Jul 6;360(9326):58-60. doi: 10.1016/S0140-6736(02)09336-4.
10
In vivo sensitivity monitoring of chloroquine for the treatment of uncomplicated vivax malaria in four bordered provinces of Thailand during 2009-2010.2009 - 2010年泰国四个边境省份氯喹治疗非复杂性间日疟的体内敏感性监测
J Vector Borne Dis. 2011 Dec;48(4):190-6.

引用本文的文献

1
The prevention and treatment of Plasmodium vivax malaria.疟原虫 vivax 疟疾的预防和治疗。
PLoS Med. 2021 Apr 23;18(4):e1003561. doi: 10.1371/journal.pmed.1003561. eCollection 2021 Apr.
2
Management of relapsing Plasmodium vivax malaria.复发性间日疟的管理
Expert Rev Anti Infect Ther. 2016 Oct;14(10):885-900. doi: 10.1080/14787210.2016.1220304. Epub 2016 Aug 31.
3
Efficacy and safety of artemisinin combination therapy (ACT) for non-falciparum malaria: a systematic review.青蒿素联合疗法治疗非恶性疟的疗效与安全性:一项系统评价
Malar J. 2014 Nov 26;13:463. doi: 10.1186/1475-2875-13-463.
4
In vivo efficacy of artemether-lumefantrine and chloroquine against Plasmodium vivax: a randomized open label trial in central Ethiopia.在体疗效的蒿甲醚-本芴醇和氯喹对间日疟原虫:在埃塞俄比亚中部的随机开放标签试验。
PLoS One. 2013 May 22;8(5):e63433. doi: 10.1371/journal.pone.0063433. Print 2013.
5
Malaria distribution, prevalence, drug resistance and control in Indonesia.印度尼西亚的疟疾分布、流行情况、耐药性和控制情况。
Adv Parasitol. 2011;74:41-175. doi: 10.1016/B978-0-12-385897-9.00002-1.
6
Chloroquine resistance in Plasmodium vivax.间日疟原虫的氯喹耐药性
Antimicrob Agents Chemother. 2004 Nov;48(11):4075-83. doi: 10.1128/AAC.48.11.4075-4083.2004.
7
Resurgent malaria at the millennium: control strategies in crisis.千年之际疟疾卷土重来:危机中的控制策略
Drugs. 2000 Apr;59(4):719-43. doi: 10.2165/00003495-200059040-00001.